Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KMC Speciality Hospitals (India)BOM:524520 -2.21%87 Return-on-Tangible-Equity is 27.81% as of Mar. 2026, which is 11% above its 10-year median of 25.03. GuruFocus rates BOM:524520 with a GF Score™ of 87/100 and a GF Value™ of ₹127.45 (Fairly Valued). The stock has 1 warning sign investors should review. Among 577 Healthcare Providers & Services companies, KMC Speciality Hospitals (India) ranks better than 72.27% on this metric.
The historical rank and industry rank for KMC Speciality Hospitals (India)'s Return-on-Tangible-Equity or its related term are showing as below:
BOM:524520'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 13.92 Med: 25.03 Max: 31.88
Current: 25.18
During the past 13 years, KMC Speciality Hospitals (India)'s highest Return-on-Tangible-Equity was 31.88%. The lowest was 13.92%. And the median was 25.03%.
BOM:524520's Return-on-Tangible-Equity is ranked better than 72.27% of 577
companies
in the Healthcare Providers & Services industry
Industry Median: 10.62
vs BOM:524520: 25.18
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
KMC Speciality Hospitals (India) Return-on-Tangible-Equity Related Terms
KMC Speciality Hospitals (India) Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524520 vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, KMC Speciality Hospitals (India)'s Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KMC Speciality Hospitals (India) Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, KMC Speciality Hospitals (India)'s Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where KMC Speciality Hospitals (India)'s Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 27.81% mean?
KMC Speciality Hospitals (India) (BOM:524520) has a Return-on-Tangible-Equity of 27.81% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on KMC Speciality Hospitals (India) and its competitors. This is 11% above median its historical median of 25.03. Over the past decade, KMC Speciality Hospitals (India)'s Return-on-Tangible-Equity has ranged from 13.92 to 31.88. According to the industry distribution chart, KMC Speciality Hospitals (India) ranks #160 out of 577 companies in the Healthcare Providers & Services industry, placing it in the top 27.7%.
Is KMC Speciality Hospitals (India)'s Return-on-Tangible-Equity too high?
KMC Speciality Hospitals (India)'s current Return-on-Tangible-Equity of 27.81% is 11% above median its 10-year median of 25.03. Over the past 10 years, this metric has ranged from a low of 13.92 to a high of 31.88. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.62. KMC Speciality Hospitals (India)'s value of 27.81% is 161.9% above this industry median. Based on the distribution chart, KMC Speciality Hospitals (India) ranks #160 out of 577 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, KMC Speciality Hospitals (India) has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does KMC Speciality Hospitals (India)'s Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, KMC Speciality Hospitals (India) ranks #160 out of 577 companies for Return-on-Tangible-Equity. This puts KMC Speciality Hospitals (India) in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.62. KMC Speciality Hospitals (India)'s value of 27.81% is 161.9% above this benchmark. Historically, KMC Speciality Hospitals (India)'s own Return-on-Tangible-Equity has ranged from 13.92 to 31.88 over the past decade. While the company's 10-year median is 25.03 vs. the industry median of 10.62, KMC Speciality Hospitals (India) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.62, based on 577 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KMC Speciality Hospitals (India)'s current Return-on-Tangible-Equity of 27.81% is 161.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on KMC Speciality Hospitals (India) and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KMC Speciality Hospitals (India)'s current Return-on-Tangible-Equity is 27.81%, which is 11% above median its own 10-year median of 25.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMC Speciality Hospitals (India) stock overvalued right now?
Based on GuruFocus' analysis, KMC Speciality Hospitals (India) (BOM:524520) is currently considered Fairly Valued. The stock's GF Value™ is ₹127.45, compared to a current price of ₹119.45 — trading 6.3% below its estimated fair value. The current Return-on-Tangible-Equity is 27.81%, which is 11% above median its 10-year median of 25.03 and 161.9% above the Healthcare Providers & Services industry median of 10.62. KMC Speciality Hospitals (India)'s overall GF Score™ is 87/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For KMC Speciality Hospitals (India) (BOM:524520), the current Return-on-Tangible-Equity is 27.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KMC Speciality Hospitals (India) (BOM:524520) Overvalued in 2026?
Based on GuruFocus' analysis, KMC Speciality Hospitals (India) stock appears to be undervalued.
The current stock price of ₹119.45 is trading 6.3% below its estimated GF Value™ of ₹127.45.
GuruFocus considers KMC Speciality Hospitals (India) to be Fairly Valued.
Key valuation signals for BOM:524520:
Return-on-Tangible-Equity: 27.81% (11% above median its 10-year median of 25.03)
GF Value™: ₹127.45 vs. price of ₹119.45 (6.3% below fair value)
Industry Position: 161.9% above the Healthcare Providers & Services median (#160 of 577)
No single metric tells the full story. See the BOM:524520 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KMC Speciality Hospitals (India) Ltd is a healthcare services and pharmacy company. It is engaged in the business of rendering medical and healthcare services. The company offers varieties of departments and care centers such as cardiac science, neurology and neuroscience, orthopedics, spine surgery, gastroenterology, liver diseases, and transplantation and vascular surgery. The company's sole operating segment is Medical and Healthcare Services. The company operates solely in India.
87GF Score
Get the complete analysis for BOM:524520
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524520 has been successfully added to your 
